|
Sign In to gain access to subscriptions and/or personal tools.
|
Review : Transverse myelopathy in SLE: clinical features and functional outcomes
K-F. Chan
Department of Rehabilitation Medicine, Tan Tock Seng Hospital, Singapore
M-L. Boey
Dept of Rheumatology/ Immunology, Tan Tock Seng Hospital, Singapore
The objective of the study was to examine the clinical features of lupus patients who present with transverse myelopathy (TM) and ascertain functional outcomes when treated early with high dose corticosteroids and/or cyclophosphamide. Case records of nine patients who developed a total of 14 episodes of TM were retrospectively studied. All the patients were female and their ages ranged from 21 to 59 years. Nine episodes of paraperesis, three of tetraperesis, one of numbness and one of neurogenic bladder were reported early in the diagnosis of SLE (median of two years). Neurogenic bowel and bladder and presence of ANA and ds-DNA were invariable. Urodynamics assessment in six patients showed abnor mal detrusor behavior in all. CT scans and myelograms were uninformative and CSF studies were normal. ESR and complement levels were insensitive as markers of disease activity. The treatment regimens included pulses of methylprednisolone and/or cyclophos phamide followed by prednisolone and high dose prednisolone from onset. The functional outcomes were uniformly good - with independent ambulation in all except three (who needed assistive devices) and improvement of motor scores. Acute hospital stays were short (range of three to 45 days) whilst only two were referred for inpatient rehabilitation. Bladder abnormalities persisted despite motor recovery and would require long-term review.
Key Words: Transverse myelopathy • SLE • functional outcomes
Lupus, Vol. 5, No. 4,
294-299 (1996)
DOI: 10.1177/096120339600500409
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
S. Ferreira, P. Marques, E. Carneiro, D. D'Cruz, and G. Gama
Devic's syndrome in systemic lupus erythematosus and probable antiphospholipid syndrome
Rheumatology,
May 1, 2005;
44(5):
693 - 695.
[Full Text]
[PDF]
|
|
|
|
|
|
|
L Barile-Fabris, R Ariza-Andraca, L Olguin-Ortega, L J Jara, A Fraga-Mouret, J M Miranda-Limon, J Fuentes de la Mata, P Clark, F Vargas, and J Alocer-Varela
Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus
Ann Rheum Dis,
April 1, 2005;
64(4):
620 - 625.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J Sastre-Garriga and X Montalban
APS and the brain
Lupus,
December 1, 2003;
12(12):
877 - 882.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J. de Seze, T. Stojkovic, G. Breteau, C. Lucas, U. Michon-Pasturel, J.-Y. Gauvrit, E. Hachulla, F. Mounier-Vehier, J.-P. Pruvo, D. Leys, et al.
Acute myelopathies: Clinical, laboratory and outcome profiles in 79 cases
Brain,
August 1, 2001;
124(8):
1509 - 1521.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K Takada, G G Illei, and D T Boumpas
Cyclophosphamide for the treatment of systemic lupus erythematosus
Lupus,
March 1, 2001;
10(3):
154 - 161.
[Abstract]
[PDF]
|
|
|
|
|
|
|
S J M WEATHERBY, M B DAVIES, C P HAWKINS, N HAQ, and P DAWES
Transverse myelopathy, a rare complication of mixed connective tissue disease: comparison with SLE related transverse myelopathy
J. Neurol. Neurosurg. Psychiatry,
April 1, 2000;
68(4):
532a - 533.
[Full Text]
|
|
|
|
|
|
|
B. Kovacs, T. L Lafferty, L. H Brent, and R. J DeHoratius
Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature
Ann Rheum Dis,
February 1, 2000;
59(2):
120 - 124.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
H. Osawa, H. Yamabe, M. Kaizuka, N. Tamura, S. Tsunoda, K. Shirato, and K. Okumura
Systemic lupus erythematosus associated with transverse myelitis and Parkinsonian symptoms
Lupus,
January 1, 1997;
6(7):
613 - 615.
[Abstract]
[PDF]
|
|
|
|
|
